Status:
COMPLETED
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
45+ years
Brief Summary
This study is investigating how patients with severe stable state COPD perceive the variability of their symptoms throughout the day, the week and the year; the impact of these variations on their dai...
Eligibility Criteria
Inclusion
- Outpatients with a diagnosis of COPD
- FEV1\<50% and FEV1/FVC\<0.7 according to lung function data in medical records.
- Smoker or ex-smoker \> 10 pack-years
- Informed consent obtained
Exclusion
- Ongoing exacerbation of COPD or within the previous 3 months
- Any other significant respiratory disease (including asthma and allergic rhinitis)
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
7400 Patients enrolled
Trial Details
Trial ID
NCT00722267
Start Date
July 1 2008
End Date
February 1 2009
Last Update
January 22 2020
Active Locations (606)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Baden, Austria
2
Research Site
Feldbach, Austria
3
Research Site
Feldkirch, Austria
4
Research Site
Güssing, Austria